Global Financial Private Capital LLC grew its position in Stryker Corporation (NYSE:SYK) by 10.2% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 15,500 shares of the medical technology company’s stock after purchasing an additional 1,440 shares during the period. Global Financial Private Capital LLC’s holdings in Stryker Corporation were worth $2,151,000 as of its most recent filing with the SEC.

Several other large investors have also recently modified their holdings of the company. Bollard Group LLC boosted its stake in shares of Stryker Corporation by 0.4% in the 2nd quarter. Bollard Group LLC now owns 832 shares of the medical technology company’s stock valued at $115,000 after purchasing an additional 3 shares in the last quarter. Assetmark Inc. raised its holdings in shares of Stryker Corporation by 0.3% in the first quarter. Assetmark Inc. now owns 1,274 shares of the medical technology company’s stock valued at $168,000 after buying an additional 4 shares during the last quarter. Blue Chip Partners Inc. raised its holdings in shares of Stryker Corporation by 0.3% in the first quarter. Blue Chip Partners Inc. now owns 1,775 shares of the medical technology company’s stock valued at $234,000 after buying an additional 6 shares during the last quarter. Guardian Life Insurance Co. of America raised its holdings in shares of Stryker Corporation by 0.8% in the first quarter. Guardian Life Insurance Co. of America now owns 1,199 shares of the medical technology company’s stock valued at $158,000 after buying an additional 9 shares during the last quarter. Finally, FineMark National Bank & Trust raised its holdings in shares of Stryker Corporation by 0.4% in the second quarter. FineMark National Bank & Trust now owns 3,878 shares of the medical technology company’s stock valued at $538,000 after buying an additional 15 shares during the last quarter. Institutional investors own 74.10% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This article was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another site, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this article can be viewed at https://www.thecerbatgem.com/2017/10/16/stryker-corporation-syk-stake-raised-by-global-financial-private-capital-llc.html.

In related news, insider Graham A. Mclean sold 1,124 shares of Stryker Corporation stock in a transaction that occurred on Tuesday, August 8th. The stock was sold at an average price of $146.26, for a total transaction of $164,396.24. Following the transaction, the insider now owns 8,983 shares of the company’s stock, valued at $1,313,853.58. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Lonny J. Carpenter sold 5,000 shares of Stryker Corporation stock in a transaction that occurred on Friday, August 4th. The shares were sold at an average price of $146.36, for a total value of $731,800.00. Following the transaction, the insider now directly owns 88,207 shares in the company, valued at approximately $12,909,976.52. The disclosure for this sale can be found here. Insiders own 7.40% of the company’s stock.

A number of research analysts recently issued reports on the company. Cowen and Company set a $160.00 price target on Stryker Corporation and gave the company a “buy” rating in a report on Friday, October 6th. Zacks Investment Research cut Stryker Corporation from a “buy” rating to a “hold” rating in a report on Thursday, August 17th. BidaskClub raised Stryker Corporation from a “hold” rating to a “buy” rating in a report on Thursday, August 17th. Royal Bank Of Canada lifted their price target on Stryker Corporation from $140.00 to $155.00 and gave the company an “outperform” rating in a report on Friday, July 28th. Finally, Oppenheimer Holdings, Inc. set a $148.00 price target on Stryker Corporation and gave the company a “hold” rating in a report on Friday, July 28th. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and twelve have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $146.78.

Stryker Corporation (NYSE:SYK) opened at 146.69 on Monday. The firm has a market cap of $54.87 billion, a P/E ratio of 32.74 and a beta of 0.81. The firm’s 50-day moving average price is $143.05 and its 200-day moving average price is $140.60. Stryker Corporation has a 52-week low of $106.48 and a 52-week high of $149.23.

Stryker Corporation (NYSE:SYK) last released its quarterly earnings data on Thursday, July 27th. The medical technology company reported $1.53 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.51 by $0.02. The firm had revenue of $3.01 billion during the quarter, compared to the consensus estimate of $2.98 billion. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. The company’s quarterly revenue was up 6.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.39 earnings per share. Equities research analysts expect that Stryker Corporation will post $6.45 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 31st. Stockholders of record on Friday, September 29th will be issued a dividend of $0.425 per share. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $1.70 annualized dividend and a dividend yield of 1.16%. Stryker Corporation’s dividend payout ratio is 37.95%.

About Stryker Corporation

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Stock Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related stocks with our FREE daily email newsletter.